• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素逃逸的诊断及去势术在前列腺癌中的作用

The diagnosis of oestrogen escape and the role of secondary orchiectomy in prostatic cancer.

作者信息

Stone A R, Hargreave T B, Chisholm G D

出版信息

Br J Urol. 1980 Dec;52(6):535-8. doi: 10.1111/j.1464-410x.1980.tb03109.x.

DOI:10.1111/j.1464-410x.1980.tb03109.x
PMID:7459586
Abstract

The criteria for the diagnosis of progression of prostatic cancer after primary treatment by androgen suppression (oestrogen escape) were studied in 30 patients. Objective criteria are essential for this diagnosis and in this study the bone scan was the most useful criterion. Twenty-one of these patients had a secondary orchiectomy: one patient showed a partial objective response and 3 had a subjective response. It is concluded that an orchiectomy following failed primary oestrogen therapy is an ineffective procedure and therefore unjustifiable and that alternative treatments must continue to be evaluated.

摘要

对30例经雄激素抑制(雌激素逃逸)进行初始治疗后的前列腺癌进展诊断标准进行了研究。该诊断需要客观标准,在本研究中骨扫描是最有用的标准。其中21例患者接受了二次睾丸切除术:1例患者显示部分客观缓解,3例有主观缓解。得出的结论是,初始雌激素治疗失败后进行睾丸切除术是无效的程序,因此不合理,必须继续评估替代治疗方法。

相似文献

1
The diagnosis of oestrogen escape and the role of secondary orchiectomy in prostatic cancer.雌激素逃逸的诊断及去势术在前列腺癌中的作用
Br J Urol. 1980 Dec;52(6):535-8. doi: 10.1111/j.1464-410x.1980.tb03109.x.
2
Comparison of primary orchiectomy with oestrogen therapy in advanced prostatic cancer. A 2-year follow-up report of a national, prospective prostatic cancer study.
Br J Urol. 1986 Oct;58(5):528-33. doi: 10.1111/j.1464-410x.1986.tb05461.x.
3
Sexual function in prostatic cancer patients treated with radiotherapy, orchiectomy or oestrogens.接受放疗、睾丸切除术或雌激素治疗的前列腺癌患者的性功能。
Br J Urol. 1984 Feb;56(1):64-9. doi: 10.1111/j.1464-410x.1984.tb07166.x.
4
Some effects of orchiectomy, oestrogen treatment and radiation therapy in patients with prostatic carcinoma.睾丸切除术、雌激素治疗及放射疗法对前列腺癌患者的一些影响。
Scand J Urol Nephrol Suppl. 1983;77:1-37.
5
The effects of orchiectomy, oestrogens and cyproterone-acetate on the antithrombin-III concentration in carcinoma of the prostate.睾丸切除术、雌激素及醋酸环丙孕酮对前列腺癌患者抗凝血酶III浓度的影响
Urol Res. 1981;9(1):25-8. doi: 10.1007/BF00256835.
6
The effect of cyproterone acetate and orchiectomy on metastases from prostatic cancer.醋酸环丙孕酮和睾丸切除术对前列腺癌转移的影响。
Eur Urol. 1980;6(3):149-53. doi: 10.1159/000473314.
7
Treatment of advanced prostatic carcinoma with cyproterone acetate and orchiectomy--5-year follow-up.醋酸环丙孕酮与睾丸切除术治疗晚期前列腺癌——5年随访
Eur Urol. 1980;6(3):145-8. doi: 10.1159/000473313.
8
High dose polyoestradiol phosphate with and without acetosalicylic acid versus orchiectomy in the treatment of prostatic cancer. Finnprostate Group.高剂量聚磷酸雌二醇联合或不联合乙酰水杨酸与睾丸切除术治疗前列腺癌的对比研究。芬兰前列腺研究组。
Br J Urol. 1989 May;63(5):512-4. doi: 10.1111/j.1464-410x.1989.tb05946.x.
9
Plasma androgen levels after subcapsular orchiectomy or estrogen treatment for prostatic carcinoma.前列腺癌行包膜下睾丸切除术后或雌激素治疗后的血浆雄激素水平。
Prostate. 1982;3(2):115-21. doi: 10.1002/pros.2990030203.
10
Orchiectomy versus oestrogen in the treatment of advanced prostatic cancer.睾丸切除术与雌激素治疗晚期前列腺癌的对比
Br J Urol. 1991 Feb;67(2):184-7. doi: 10.1111/j.1464-410x.1991.tb15106.x.

引用本文的文献

1
Treatment algorithm in hormone-resistant prostate cancer: Practical guidelines.激素抵抗性前列腺癌的治疗算法:实用指南。
Indian J Urol. 2007 Jan;23(1):67-9. doi: 10.4103/0970-1591.30271.
2
A tribute to professor Geoffrey D Chisholm CBE ChM PPRCS Ed FRCS Eng FRCP Ed FRCPSG FRACS (Hon) FCSSA (Hon) FACS (Hon) FRSE.向杰弗里·D·奇泽姆教授致敬,他拥有大英帝国司令勋章(CBE)、医学硕士(ChM)、皇家外科医学院院士(PPRCS Ed)、英国皇家外科医学院院士(FRCS Eng)、爱丁堡皇家内科医学院院士(FRCP Ed)、格拉斯哥皇家内科及外科医学院院士(FRCPSG)、澳大利亚皇家外科学院荣誉院士(FRACS (Hon))、澳大利亚临床科学协会荣誉院士(FCSSA (Hon))、美国外科学院荣誉院士(FACS (Hon))、爱丁堡皇家学会院士(FRSE)。
J R Soc Med. 1996;89 Suppl 29(Suppl 29):3-12.
3
The effect of previous endocrine therapy on responses to a single dose of an LHRH analogue.
既往内分泌治疗对单次剂量促性腺激素释放激素类似物反应的影响。
Urol Res. 1984;12(5):249-51. doi: 10.1007/BF00256149.
4
Hormonal aspects of prostatic cancer: a review.前列腺癌的激素方面:综述
J R Soc Med. 1985 Feb;78(2):129-35. doi: 10.1177/014107688507800212.
5
[Problems and principles of hormone therapy of advanced prostate cancer].[晚期前列腺癌激素治疗的问题与原则]
Klin Wochenschr. 1990 Apr 2;68(7):347-58. doi: 10.1007/BF01650885.